Anaplasmosis and Ehrlichiosis
Safety Classified by Officially
Anaplasma phagocytophilum and Ehrlichia chaffeensis are related bacteria which are transmitted by ticks and cause infections in humans and some animal species.
Anaplasma has a wide distribution across North America and Eurasia. Anaplasmosis is the disease caused by A. phagocytophilum infection and is relatively mild in the majority of cases.
The main species of Ehrlichia is limited to North America. Ehrlichiosis, the disease resulting from infection with Ehrlichia spp., can cause significant and even life-threatening disease, requiring urgent treatment.
Anaplasmosis, also known as Human Granulocytic Anaplasmosis (HGA) is spread through bites from Ixodes ticks. These are widespread across Europe, the UK and North America. Ixodes ricinus, the European species, can also transmit tick-borne encephalitis and other infections, but studies in Europe have found that infections with more than one tick-borne pathogen at a time are very rare. In North America, I. scapularis and I. pacificus transmit A. phagocytophilum and are also the vectors for Lyme disease.
A. phagocytophilum infects a wide range of animal hosts including wild and domestic ruminants, horses, birds, rodents and domesticated dogs and cats. It causes tick-borne fever in sheep, and pasture fever in cattle, with significant economic consequences.
The vast majority of anaplasmosis cases in humans are seen in North America. Cases are rarely reported in Europe and, in the UK, only one case of human anaplasmosis has been documented, acquired in Scotland where the pathogen is highly endemic in animals.
Most cases in humans go unnoticed. Those who develop illness generally have fever, muscle aches and pains, chills and joint pains. A few cases may have more significant symptoms including breathing difficulties and kidney failure. In these cases, urgent treatment is required.
A blood film taken early after the onset of symptoms may show clusters (called morulae) of bacteria in granulocytic white blood cells.
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/guidance/anaplasmosis-and-ehrlichiosis
Officially imported this from UK Health Security Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- UK Health Security Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/uk-health-security-agency.atom ATOM
- Imported
- November 09, 2026 13:01
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/guidance/anaplasmosis-and-ehrlichiosis#2026-11-09T12:19:59Z